This inventor holds 1 USPTO granted patent. Top assignee: National Jewish Center for Immunology and Respiratory Medicine. Active years: 1993.
Company Filing History:
Years Active: 1993
Title: Soren Buus: Innovator in Polypeptide Vaccine Development
Introduction
Soren Buus is a prominent inventor based in Copenhagen, Denmark. He has made significant contributions to the field of immunology, particularly in the development of polypeptide vaccines. His innovative approach has the potential to enhance vaccine efficacy against various pathogens.
Latest Patents
Soren Buus holds a patent for a method of identifying useful polypeptide vaccines. This method involves ascertaining a critical binding segment of a first polypeptide known to bind to a first MHC type. The process evaluates the effect of replacing each amino acid in the critical segment on its binding to the MHC type. Subsequently, a protein produced by the agent is scanned for trial amino acid sequences that may serve as good binders. When a promising binding sequence is identified, a polypeptide containing that sequence can be evaluated as a synthetic vaccine. This innovative method has the potential to advance vaccine development significantly.
Career Highlights
Soren Buus has had a distinguished career, working at the National Jewish Center for Immunology and Respiratory Medicine. His research focuses on the intersection of immunology and vaccine development, contributing to advancements in the field.
Collaborations
Soren has collaborated with notable scientists, including Alessandro Sette and Howard M Grey. These collaborations have further enriched his research and contributed to the development of effective vaccine strategies.
Conclusion
Soren Buus is a key figure in the field of immunology, with a focus on polypeptide vaccine development. His innovative methods and collaborations have the potential to make a significant impact on vaccine efficacy and public health.